The diagnosis of BC in BRCA1/2Mut+ carriers has shown to affect the likelihood of postmastectomy reconstruction [3], and a relationship between patient demographics and type of reconstruction has been seen [2]. The gene discussed is BRCA1; the disease is breast cancer.